# 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

> **NCT05891769** · PHASE2,PHASE3 · RECRUITING · sponsor: **Andrei Iagaru** · enrollment: 100 (estimated)

## Conditions studied

- Parathyroid Adenoma

## Interventions

- **DRUG:** 18Fluorocholine

## Key facts

- **NCT ID:** NCT05891769
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-27
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05891769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05891769, "99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05891769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*